Bolivian Region Authorizes Ivermectin as Treatment Against COVID-19

Bolivian Region Authorizes Ivermectin as Treatment Against COVID-19

TrialSite News continues to monitor the ivermectin story with interest. Now a city in Bolivia called Trinidad initiated a campaign to combat COVID-19 by handing out free doses of the anti-parasite drug in an effort to take on the pathogen in the eastern region of the country where more have contracted the virus. TrialSite News’ sources report of growing interest—and even authorization—of ivermectin in some of the more economically challenged South American nations. Is this faith in something not scientifically proven based on desperation or do they know something we don’t?

Ivermectin in Story in a Nutshell

Australian universities (Monash University & Peter Doherty Institute) identified the possibility of ivermectin treating COVID-19 in a lab setting in a cell culture within 48 hours. Critics declared this was done with larger doses in vitro not duplicative in human clinical trials. However, the work from the path-breaking scientists in Australia planted the seed of scientific curiosity in researchers around the world. Hence, now ivermectin proof-of-concept-based human clinical trials are now occurring in the following:

University of Tanta, EgyptMansoura University, Eg...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee